Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients

Journal of Parenteral and Enteral Nutrition

Volumn 32, Issue 4, 2008, Pages 389-402

  Estívariz, Concepción F ^a,b   Griffith, Daniel P ^a,c   Menghua Luo, ^a,c   Szeszycki, Elaina E ^a   Bazargan, Niloofar ^a,b   Dave, Nisha ^a,c   Daignault, Nicole M ^a   Bergman, Glen F ^a   McNally, Therese ^a   Battey, Cindy H ^a   Furr, Celeste E ^a   Hao, Li ^b,c   Ramsay, James G ^b   Accardi, Carolyn R ^b,c   Cotsonis, George A ^c   Jones, Dean P ^b,c   Galloway, John R ^a,b,c   Ziegler, Thomas R ^a,b,c  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Critical illness; Glutamine; Hospital infections; Parenteral nutrition

Indexed keywords

ALANYLGLUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLON SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; HEART SURGERY; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PANCREAS NECROSIS; PARENTERAL NUTRITION; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; SUPPLEMENTATION; SURGICAL PATIENT; VASCULAR SURGERY;

FUNGI; NEGIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 45749135445     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607108317880     Document Type: Article

References (66)

1. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995 ; 274: 639-644.
2. Girou E., Stephan F., Novara A., Safar M., Fagon JY Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med. 1998 ; 157: 1151-1158.
3. Martin GS, Mannino DM, Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003 ; 348: 1546-1554.
4. Richards MJ, Edwards JR, Culver DH, Gaynes RP Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000 ; 21: 510-515.
5. Salgado CD, O'Grady N., Farr BM Prevention and control of antimicrobial-resistant infections in intensive care patients. Crit Care Med. 2005 ; 33: 2373-2382.
6. Garey KW, Neuhauser MM, Bearden DT, et al. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. Mycoses. 2006 ; 49: 226-233.
7. Fridkin SK, Jarvis WR Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996 ; 9: 499-511.
8. Park SK, Brody JI, Wallace HA, Blakemore WS Immunosuppressive effect of surgery. Lancet. 1971 ; 1: 53-55.
9. Hensler T., Hecker H., Heeg K., et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun. 1997 ; 65: 2283-2291.
10. Whelan RL, Franklin M., Holubar SD, et al. Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans. Surg Endosc. 2003 ; 17: 972-978.
11. Wilmore DW, Smith RJ, O'Dwyer ST, et al. The gut: a central organ after surgical stress. Surgery. 1988 ; 104: 917-923.
12. Swank GM, Deitch EA Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996 ; 20: 411-417.
13. Fink MP Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care. 2003 ; 9: 143-151.
14. Scrimshaw NS Historical concepts of interactions, synergism and antagonism between nutrition and infection. J Nutr. 2003 ; 133: 316S - 321S.
15. Ziegler TR, Puckett AB, Griffiths DP, Galloway JR Interactions between nutrients and growth factors in cellular growth and tissue repair. In: Ziegler TR, Pierce GF, Herndon DN, eds. Growth Factors and Wound Healing: Basic Science and Potential Clinical Applications. New York, NY: Springer-Verlag, 1997 ; 104-150.
16. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 2001 ; 325: 525-532.
17. Heyland DK, Dhaliwal R., Drover JW, Gramlich L., Dodek P. Canadian Critical Care Clinical Practice Guidelines Committee. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003 ; 27: 355-373.
18. Heyland DK, MacDonald S., Keefe L., Drover JW Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA. 1998 ; 280: 2013-2019.
19. Blumberg HM, Jarvis WR, Soucie JM,, et al. National Epidemiology of Mycoses Survey (NEMIS) Study Group. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis. 2001 ; 33: 177-186.
20. Van den Berghe G., Wouters P., Weekers F.,, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 ; 345: 1359-1367.
21. Wilmore DW The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr. 2001 ; 131 (9 suppl). 2543S - 2549S.
22. Furst P., Ziegler TR Protein and amino acid metabolism and therapy: what is new and what has been left aside. Curr Opin Clin Nutr Metab Care. 1998 ; 1: 59-65.
23. Labow BI, Souba WW Glutamine. World J Surg. 2000 ; 24: 1503-1513.
24. Calder PC, Yaqoob P. Glutamine and the immune system. Amino Acids. 1999 ; 17: 227-241.
25. Hammarqvist F., Wernerman J., Ali R., von der Decken A., Vinnars E. Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares free glutamine in muscle, counteracts the fall in muscle protein synthesis, and improves nitrogen balance. Ann Surg. 1989 ; 209: 455-461.
26. Roth E., Zoch G., Schulz F., et al. Amino acid concentrations in plasma and skeletal muscle of patients with acute hemorrhagic necrotizing pancreatitis. Clin Chem. 1985 ; 31: 1305-1309.
27. Stehle P., Zander J., Mertes N., et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989 ; 1: 231-233.
28. Parry-Billings M., Baigrie RJ, Lamont PM, Morris PJ, Newsholme EA Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg. 1992 ; 127: 1237-1240.
29. Oudemans-van Straaten HM, Bosman RJ, Treskes M., van der Spoel HJ, Zandstra DF Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001 ; 27: 84-90.
30. Furst P. Old and new substrates in clinical nutrition. J Nutr. 1998 ; 128: 789-796.
31. Ziegler TR, Young LS, Benfell K., et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation: a randomized, double-blind, controlled study. Ann Intern Med. 1992 ; 116: 821-828.
32. Mertes N., Schulzki C., Goeters C., et al. Cost-containment through L-alanyl-L-glutamine supplemented total parenteral nutrition after major abdominal surgery: a prospective, randomized, double-blind controlled study. Clin Nutr. 2000 ; 19: 395-401.
33. Karwowska KA, Dworacki G., Trybus M., Zeromski J., Szulc R. Influence of glutamine-enriched parenteral nutrition on nitrogen balance and immunologic status in patients undergoing elective aortic aneurysm repair. Nutrition. 2001 ; 17: 475-478.
34. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet. 1993 ; 341: 1363-1365.
35. Tremel H., Kienle B., Weilemann LS, Stehle P., Furst P. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology. 1994 ; 107: 1595-1601.
36. O'Riordain MG, Fearon KCH, Ross JA, et al. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg. 1994 ; 220: 212-221.
37. Ziegler TR, Bye RL, Persinger RL, et al. Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci. 1998 ; 315: 4-10.
38. Exner R., Tamandl D., Goetzinger P., et al. Perioperative GLY-GLN infusion diminishes the surgery-induced period of immunosuppression: accelerated restoration of the lipopolysaccharide-stimulated tumor necrosis factor-alpha response. Ann Surg. 2003 ; 237: 110-115.
39. Wischmeyer PE, Lynch J., Liedel J., et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001 ; 29: 2075-2080.
40. Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition. 2002 ; 18: 546-552.
41. Fuentes-Orozco C., Anaya-Prado R., Gonzalez-Ojeda A., et al. L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004 ; 23: 13-21.
42. Dechelotte P., Hasselmann M., Cynober L., et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006 ; 34: 598-604.
43. Griffiths RD, Jones C., Palmer TE Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. 1997 ; 13: 295-302.
44. Goeters C., Wenn A., Mertes N., et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002 ; 30: 2032-2037.
45. Novak F., Heyland DK, Avenell A., Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002 ; 30: 2022-2029.
46. van Zaanen HC, van der Lelie H., Timmer JG, Furst P., Sauerwein HP Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer. 1994 ; 74: 2879-2884.
47. Schloerb PR, Skikne BS Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN J Parenter Enteral Nutr. 1999 ; 23: 117-122.
48. Powell-Tuck J., Jamieson CP, Bettany GE, et al. A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition. Gut. 1999 ; 45: 82-88.
49. Pytlik R., Benes P., Patorkova M., et al. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transpl. 2002 ; 30: 953-961.
50. Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. National Institute of Child Health and Human Development Neonatal Research Network. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics. 2004 ; 113: 1209-1215.
51. Ockenga J., Borchert K., Stuber E., et al. Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr. 2005 ; 59: 1302-1309.
52. Albers MJ, Steyerberg EW, Hazebroek FW, et al. Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestive-tract surgery: results from a double-blind, randomized, controlled trial. Ann Surg. 2005 ; 241: 599-606.
53. Alpers DH Glutamine: do the data support the cause for glutamine supplementation in humans? Gastroenterology. 2006 ; 130 (2 suppl 1). S106 - S116.
54. Bernard GR, Artigas A., Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994 ; 149: 818-824.
55. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM CDC definitions for nosocomial infections. Am J Infect Control. 1988 ; 16: 128-140.
56. Knaus WA APACHE 1978-2001: the development of a quality assurance system based on prognosis: milestones and personal reflections. Arch Surg. 2002 ; 137: 37-41.
57. van der Lely AJ, Veelo DP, Dongelmans DA, et al. Time to wean after tracheotomy differs among subgroups of critically ill patients: retrospective analysis in a mixed medical/surgical intensive care unit. Respir Care. 2006 ; 51: 1408-1415.
58. Steininger R., Karner J., Roth E., Langer K. Infusion of dipeptides as nutritional substrates for glutamine, tyrosine, and branched-chain amino acids in patients with acute pancreatitis. Metabolism. 1989 ; 38: 78-81.
59. de Beaux AC, O'Riordain MG, Ross JA, et al. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition. 1998 ; 14: 261-265.
60. Ockenga J., Borchert K., Rifai K., Manns MP, Bischoff SC Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin Nutr. 2002 ; 21: 409-416.
61. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002 ; 236: 814-822.
62. Alonso de Vega JM, Diaz J., Serrano E., Carbonell LF Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med. 2002 ; 30: 1782-1786.
63. Evans ME, Jones DP, Ziegler TR Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells. J Nutr. 2003 ; 133: 3065-3071.
64. Flaring UB, Rooyackers OE, Wernerman J., Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci (Lond). 2003 ; 104: 275-282.
65. Ziegler TR, Ogden LG, Singleton KD, et al. Parenteral glutamine increases serum heat shock protein-70 in critically ill patients. Intensive Care Med. 2005 ; 31: 1079-1086.
66. Finney SJ, Zekveld C., Elia A., Evans TW Glucose control and mortality in critically ill patients. JAMA. 2003 ; 290: 2041-2047.